Day: December 30, 2025

Tainan City, Taiwan, Dec. 30, 2025 (GLOBE NEWSWIRE) — Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing innovative biomedical products for precision medicine and advanced diagnostics, today announced that on December 23, 2025, it entered into an agreement (the “Agreement”) with an unrelated third party, Wei Ha Hui (the “Buyer”), pursuant to which the Company agreed to sell 100% of the issued and outstanding shares of Advanced Biomed (HK) Limited, a Hong Kong company and a wholly owned subsidiary of the Company (the “Hong Kong Subsidiary”), for an aggregate purchase price of US$23,000 based on a valuation report commissioned by the Company, subject to the terms and conditions set forth in the Agreement. All intellectual property owned by the...

Los Angeles , Dec. 30, 2025 (GLOBE NEWSWIRE) — Triller Group Inc. (“Triller Group” or “the Company”) today announced that it received a determination letter from a Nasdaq Hearings Panel on December 26, 2025, confirming the suspension of trading on the Nasdaq Stock Market effective at the open of the market on December 30, 2025 and delisting of the Company’s securities. This decision stems from the Company not having been able to file two periodic reports by a deadline of December 24, 2025 set by the Hearings Panel. The Company’s operations have been progressing in a normal manner, and no deficiencies or irregularities have been identified that materially affect the Company’s financial position or operational integrity. The filing delay is attributable primarily to one remaining technical matter involving the consolidation of accounts...

BOCA RATON, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) — Totaligent, Inc. (OTCID: TGNT) (“the Company”), a provider of intelligent business marketing and data solutions, today announced that it is evaluating the potential relaunch of its crypto mining operations as part of the Company’s strategic initiatives for 2026. This review follows the Company’s recent completion of QA testing across key components of the Totaligent platform, including Smart Capture, Display Ads, Analytics, Pulse, and campaign management tools, supporting the platform’s continued progression toward broader market deployment. As the platform advances, Totaligent is expanding its focus to include a review of its technology roadmap and operational requirements to support future product enhancements and scalability. Evaluating AI Capabilities and Strategic Participation...

HONG KONG, Dec. 30, 2025 (GLOBE NEWSWIRE) — Visionary Holdings Inc. (“GV” or the “Company”), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited（“GV Hong Kong”）, has official appointed Ms. Wenxuan Cai as Chief Executive Officer of GV Hong Kong, effective immediately. In parallel, the GV Hong Kong has established a new wholly owned subsidiary in Nanjing, China, dedicated primarily to sales execution and market development. This milestone marks GV’s formal transition from strategic positioning to active on-the-ground revenue generation. Strengthening Leadership to Drive Market Execution Ms. Cai joins the Company with nearly two decades of extensive experience in market expansion, brand commercialization, and building...

Rokiškio sūris, AB, announces that in 2026 the Group of Rokiškio sūris, AB, plans to publish its results in the following order: 8 April 2026, Audited consolidated financial statements of the Group. 31 August 2026, six-month consolidated financial statements of the Group. Dalius Trumpa CEO +370 458 55200

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today issued the following letter to shareholders from its President and Chief Executive Officer, Abizer Gaslightwala.                                    Dear Fellow Shareholders, As 2025 concludes, I am pleased to reflect on a year of meaningful progress and significant achievements towards creating best-in-class ADCs to transform current cancer therapies. With each forward step and each new milestone, we are advancing our mission to bring our innovative and uniquely designed ADCs to cancer patients with the highest unmet needs. The scientific and operational strides made this year have positioned Akari for what we believe will be a pivotal...

The new energy group EPSO-G (company code 302826889, registered office address: Laisvės pr. 10, Vilnius, Lithuania). The Ministry of Energy of the Republic of Lithuania, being the sole shareholder of EPSO-G, has adopted a decision on the appointment of the audit firm and the approval of terms of remuneration for audit services for 2026–2028 as follows:to appoint KPMG Baltics UAB, legal entity code 111494971, as the audit firm to carry out the audit of the consolidated and separate financial statements of EPSO-G, UAB for the period 2026-2028, and the audit of the consolidated management report prepared in accordance with International Financial Reporting Standards as adopted by the EU; to fix the remuneration for the audit services referred to in paragraph 1 of this Decision for the period 2026 to 2028 at a maximum of EUR 433,675 (excluding...

Publication date of audited financial reports and annual management report is corrected. INVL Baltic Farmland plans to publish information to investors in 2026 in accordance with the following calendar: 27 February – 2 March 2026 – audited financial reports and annual management report;19 May 2026 – preliminary operating results and factsheet for 3 months of 2026;18 August 2026 – semi-annual management report of 2026;17 November 2026 – preliminary operating results and factsheet for 9 months of 2026. The person authorized to provide additional information:Director Egle SurplieneE-mail: egle.surpliene@invaldainvl.com